Related Guides
Continue your research with these related independent reviews.
How to Microdose Tirzepatide: Doses, Measurement, and Getting Started
A tirzepatide microdose is any dose below the standard 2.5mg starting prescription — typically 1.0–1.25mg/week. It requires compounded tirzepatide (auto-injector pens don't allow sub-2.5mg dosing) and physician oversight. Here's how it works in practice.
The microdose math
| Target dose | Vial: 5mg/mL | Vial: 10mg/mL |
|---|---|---|
| 0.5 mg | 0.10 mL | 0.05 mL |
| 1.0 mg | 0.20 mL | 0.10 mL |
| 1.25 mg | 0.25 mL | 0.125 mL |
| 2.5 mg (standard start) | 0.50 mL | 0.25 mL |
Your pharmacy sets vial concentration — always use the instructions that come with your specific prescription. These numbers are illustrative.
For the full strategy guide — including SURMOUNT-1 dose-response data, maintenance protocols, and when microdosing makes clinical sense — see our comprehensive microdosing tirzepatide guide →This page focuses on the practical mechanics of measuring and starting a microdose.
Why Microdosing Requires Compounded Tirzepatide
- ✗Single-use auto-injector — fixed dose only
- ✗Lowest dose pen: 2.5mg (cannot go lower)
- ✗Cannot draw a partial dose — mechanism not designed for it
- ✗Dose splitting is not accurate or safe
- ✓Multi-dose vial — any dose measurable
- ✓Known concentration (e.g., 5mg/mL or 10mg/mL)
- ✓Draw exact volume with insulin syringe
- ✓Starting doses of 1.0–1.25mg fully practical
Common Tirzepatide Microdose Tiers
Extreme GI sensitivity; physician-directed only. Very limited data on efficacy.
Most common "microdose" — typically for patients with prior GLP-1 intolerance who want to re-start very slowly, or those in long-term maintenance.
Some patients stay at this level rather than titrating up. Still below the therapeutic doses studied in SURMOUNT, but within the FDA-approved titration range.
Lowest dose with substantial SURMOUNT-1 data (~15% weight loss). Sometimes used as a maintenance target after reaching goal weight on higher doses.
How to Administer a Tirzepatide Microdose
- 1Confirm your vial concentration with your pharmacy (e.g., 5mg/mL). This is printed on the vial label.
- 2Calculate the volume for your prescribed dose (dose ÷ concentration = volume in mL).
- 3Draw the calculated volume into a small insulin syringe (U-100, typically 1mL capacity).
- 4Inject subcutaneously — abdomen, thigh, or upper arm are common sites. Rotate sites weekly.
- 5Store the vial refrigerated between uses. Do not freeze. Follow your pharmacy's specific storage guidance.
- 6Keep a log of doses and injection sites. Report any new side effects to your physician.
These are general guidelines. Always follow your prescribing physician's specific instructions for your dose, injection technique, and storage requirements.
Where to Get Compounded Tirzepatide for Microdosing
Ivim Health explicitly offers customized tirzepatide protocols including 1.25mg starting doses. If microdosing is your goal, Ivim is the most direct fit.
- 1.25mg and lower starting doses available
- Individualized titration schedule
From $167/month (tirzepatide, 12-mo plan)
Compounded tirzepatide vials. Discuss preferred starting dose at intake — physicians can accommodate lower starting doses for GI-sensitive patients.
$179–$299/month
Compounded tirzepatide with verified pricing. Discuss your dosing needs with their physician team at intake.
Affiliate disclosure: GLP1CompareHub earns a commission if you enroll. See disclosure.
Frequently Asked Questions
What is a tirzepatide microdose?
A tirzepatide microdose typically refers to a dose below the standard 2.5mg FDA starting dose — usually 1.0–1.25mg per week. Some patients also use "microdose" to describe maintaining at 2.5mg long-term rather than escalating. The practice requires compounded tirzepatide in a multi-dose vial, which allows precise measurement with a small syringe.
How do you measure a tirzepatide microdose?
Compounded tirzepatide is dispensed in multi-dose vials with a known concentration (e.g., 5mg/mL or 10mg/mL). To draw a 1.25mg microdose from a 5mg/mL vial, you would draw 0.25mL using a small insulin syringe. Your compounding pharmacy will provide specific instructions based on your vial's concentration. Never attempt to split or partial-dose a branded auto-injector pen — this is not safe or reliable.
Can you microdose Mounjaro or Zepbound?
No. Mounjaro and Zepbound come as single-use auto-injector pens in fixed doses starting at 2.5mg. You cannot draw a partial dose from an auto-injector pen. Tirzepatide microdosing is only possible with compounded tirzepatide dispensed in a multi-dose vial, which allows any dose to be drawn with precision.
Does a tirzepatide microdose still cause weight loss?
Clinical data supports dose-dependent weight loss with tirzepatide. The lowest dose studied in SURMOUNT trials was 5mg (showing ~15% weight loss at 72 weeks). No randomized trial has studied sub-2.5mg doses for full-course treatment. For some patients, especially those using microdoses for maintenance after reaching goal weight, even very low doses can help prevent regain — supported indirectly by SURMOUNT-4 data showing that any continued tirzepatide beats stopping entirely.
What are the benefits of a tirzepatide microdose vs standard dose?
Primary benefits: significantly fewer GI side effects (nausea, vomiting, diarrhea), which are dose-dependent with tirzepatide. For patients who couldn't tolerate the standard 2.5mg starting dose, 1.0–1.25mg may allow them to stay on therapy rather than discontinuing. For patients in maintenance, lower doses support weight maintenance with less side effect burden compared to continuing at the peak dose (10–15mg).
Which providers offer compounded tirzepatide for microdosing?
Ivim Health specializes in customized tirzepatide dosing protocols including microdosing. TMates, Eden Health, and MEDVi also offer compounded tirzepatide in vials that enable flexible dosing — discuss your preferred starting dose with their intake physicians. All compounded tirzepatide comes from 503A pharmacies and requires a valid prescription.
Related Pages
How this page is reviewed
Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).
Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.